---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-085864"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T16:53:36.510408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Clearside Biomedical holds KOL webinar on suprachoroidal delivery; no new financial data

## Summary
- Company hosted virtual Suprachoroidal Delivery KOL Webinar on July 24, 2024.
- Attached slide presentation (Exhibit 99.1) contains only a title slide with no substantive data.
- No material financial or business updates were disclosed in the filing.

## SEC filing metadata
- accession: 0000950170-24-085864
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000095017024085864/0000950170-24-085864-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000095017024085864/clsd-20240724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-085864
- JSON: https://secwatch.observer/filing/0000950170-24-085864.json
- Plain text: https://secwatch.observer/filing/0000950170-24-085864.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.